Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Superparamagnetic iron oxide nanoparticle (SPION)-based carrier systems have many advantages over other nanoparticle-based systems. They are biocompatible, biodegradable, facilely tunable and superparamagnetic and thus controllable by an external magnetic field. These attributes enable their broad biomedical applications. In particular, magnetically driven carriers are drawing considerable interest as an emerging therapeutic delivery system because of their superior delivery efficiency. AREAS COVERED: This article reviews the recent advances in use of SPION-based carrier systems to improve the delivery efficiency and target specificity of biotherapeutics. The authors examine various formulations of SPION-based delivery systems, including SPION micelles, clusters, hydrogels, liposomes and micro/nanospheres, as well as their specific applications in delivery of biotherapeutics. EXPERT OPINION: Recently, biotherapeutics including therapeutic cells, proteins and genes have been studied as alternative treatments to various diseases. Despite the advantages of high target specificity and low adverse effects, clinical translation of biotherapeutics has been hindered by the poor stability and low delivery efficiency compared with chemical drugs. Accordingly, biotherapeutic delivery systems that can overcome these limitations are actively pursued. SPION-based materials can be ideal candidates for developing such delivery systems because of their excellent biocompatibility and superparamagnetism that enables long-term accumulation/retention at target sites by utilization of a suitable magnet. In addition, synthesis technologies for production of finely tuned, homogeneous SPIONs have been well developed, which may promise their rapid clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852 · cited 2×
“Since methods for synthesis of SPIONs and use of SPIONs as MRI contrast agents for diagnosis have been extensively reviewed [18,19], this review focuses on the SPION-based formulations that are specific to delivery of biotherapeutics.”
BackgroundMethodTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 4×
“External magnetic fields can enhance the accumulation of magnetic particles in tumors by the EPR effect.”
BackgroundInfluentialRecent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Ultra-large-scale syntheses of monodisperse nanocrystals
Park, J., An, K., Hwang, Y., Park, J.-G., Noh, H.-J., Kim, J.-Y., Park, J.-H., Hwang, N.-M., & Hyeon, T. (2004) · Nature Materials · doi:10.1038/nmat1251 · Cited by 4,076
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161 · cited 2×
“Accordingly, they have been extensively studied as a new class of drugs for treating cancers and autoimmune diseases over last decades [2-4].”
BackgroundArtificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Lee, J.-H., Huh, Y.-M., Jun, Y.-W., Seo, J.-W., Jang, J.-T., Song, H.-T., Kim, S., Cho, E.-J., Yoon, H.-G., Suh, J.-S., et al. (2007) · Nature Medicine · doi:10.1038/nm1467 · Cited by 1,897
Amstad, E., Kohlbrecher, J., Müller, E., Schweizer, T., Textor, M., & Reimhult, E. (2011) · Nano Letters · doi:10.1021/nl2001499 · Cited by 397 · cited 1×
“In a previous study, magnetic nanoparticles coated with palmityl-nitroDOPA have been successfully embedded in liposomal membranes [67].”
BackgroundPoly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance.
Raffa, V., Riggio, C., Calatayud, Hoskins, Pinkernelle, Goya, Wang, L., Keilhoff, & Cuschieri, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28460 · Cited by 83 · cited 8×
“The diverse fluidMAG particles (Chemicell) are magnetic nanoparticles coated with various polymers including chitosan, starch and PVA, and lipids [84,105].”
BackgroundMethodInfluential
Cited by
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
“Because of the presence of phosphate group, nucleic acids are negatively charged; therefore, SPIONs can be modified with cationic lipids and polymers to carry genetic materials [136].”
BackgroundCurrent Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Fundamentals and application of magnetic particles in cell isolation and enrichment: a review
Plouffe, B. D., Murthy, S. K., & Lewis, L. H. (2015) · Reports on Progress in Physics · doi:10.1088/0034-4885/78/1/016601 · Cited by 334
Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer
Truffi, M., Fiandra, L., Sorrentino, L., Monieri, M., Corsi, F., & Mazzucchelli, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.002 · Cited by 277
Yang, H. Y., Li, Y., & Lee, D. S. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800011 · Cited by 107
Metadata
- Authors
- Mok, H., & Zhang, M.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2012-12
- Volume
- 10
- Issue
- 1
- Pages
- 73-87
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2116241929
- Cited by
- 145
- References
- 8
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. https://app.cochat.ai/papers/10.1517/17425247.2013.747507
- The paper
- Mok, H., & Zhang, M. (2013). Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2013.747507
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.